Next Generation Medicine: Specialty Drug Costs, Data & Supply Chain

The latest specialty drug cost management levers that employers and plan sponsors are considering to deliver meaningful cost savings and improved patient outcomes.
By Katie King Posted on September 15, 2021

At the same time, clinical advancements have allowed for the creation of cures and treatments for a number of chronic illnesses and previously untreatable diseases.

Watch the panel discussion from The Council’s Employee Benefits Leadership Forum, which examines contracting strategies, plan design and personalized medicine.


Chris Crawford, Chief Growth Officer, Vivio Health

Joshua Fredell, PharmD, Vice President, Product Development, CVS Health

Laura Jester, Senior Director, Specialty/Pharmacy Solutions, Navitus Health Solutions

Scott Musial, Chief Pharmacy Officer, Rightway Healthcare

Moderated by: Ryan Rice, Principal & Practice Leader, Prism Health Strategists

Katie King Director, Health Policy & Strategy Read More

More in Health+Benefits

HIV-Prevention Drug Correlates with Income Gap
Health+Benefits HIV-Prevention Drug Correlates with Income Gap
Q&A with Conor Lennon, Associate Professor of Economics, Rensselaer Polytechnic ...
Health+Benefits Patient Protection
An unlikely alliance is tackling everything from cannabis to pharmacy benefit re...
Part-Time Populace
Health+Benefits Part-Time Populace
The greatest ROI is showing this often overlooked workforce that you want to pro...